Physician profile
Anthony Tarr
NPI 1821530304
$3,062.05
in general payments reported to CMS, 2019-2025
26 companies · $18.84 in 2025
The $18.84 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,341 · 2022: $867 · 2023: $753 · 2024: $82.63 · 2025: $18.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $718 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $717.65 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $550.59 | 2021-2023 | Grafix Pl |
| Tactile Systems Technology INC | $477.43 | 2021-2022 | |
| Amgen INC. | $238.68 | 2021-2022 | |
| Shockwave Medical, INC | $237.56 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $203.22 | 2021-2023 | Farxiga |
| Medical Device Business Services, INC. | $137.01 | 2023 | Stratafix |
| Janssen Pharmaceuticals, INC | $110.90 | 2021-2022 | |
| Bolton Medical INC | $104.66 | 2023-2024 | Treo Abdominal Stent-Graft System |
| Chiesi USA, INC. | $104.36 | 2021-2022 | |
| Convatec INC. | $103.36 | 2021-2023 | |
| Boston Scientific Corporation | $102.39 | 2021-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.95 | 2021-2022 | |
| Integra Lifesciences Corporation | $89.81 | 2021-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Bard Peripheral Vascular, INC. | $72.12 | 2021 | |
| Abbott Laboratories | $67.39 | 2021-2023 | Perclose Prostyle |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hydrofera LLC | $57.20 | 2023 | Hydrofera Blue |
| Kerecis Limited | $56.51 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Next Science LLC | $54.88 | 2023 | Xperience, Blastx, Surgx |
| Silk Road Medical, INC. | $50.96 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Organogenesis INC. | $37.60 | 2021 | |
| Kci USA, INC. | $25.32 | 2021 | |
| Depuy Synthes Sales INC. | $18.84 | 2025 | Dynacord, Healix Knotless Peek, Gryphon Orthocord |
| E.R. Squibb & Sons, L.L.C. | $17.40 | 2022 | |
| Reapplix INC. | $14.96 | 2021 | |
| Bsn Medical INC | $14.89 | 2022 | |
| Hartmann USA, INC. | $13.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Tarr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.